Literature DB >> 28164811

Substance Use Issues Among the Underserved: United States and International Perspectives.

Alicia Ann Kowalchuk1, Sandra J Gonzalez2, Roger J Zoorob2.   

Abstract

Substance use affects people of all ages, cultures, and socioeconomic levels. Most underserved populations have lower rates of substance use than the general population in a given society, excluding tobacco use. The impact of substance use is more severe, however, in the underserved, with higher rates of incarceration, job loss, morbidity, and mortality. Innovative solutions are being developed to address these differences. Working together, underserved patients with substance use problems can be helped on their journeys toward health and wholeness.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol; Drugs; Illicit drugs; Substance abuse; Substance use; Substance use disorders; Tobacco

Mesh:

Year:  2017        PMID: 28164811     DOI: 10.1016/j.pop.2016.09.013

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  4 in total

1.  Race and Hepatitis C Care Continuum in an Underserved Birth Cohort.

Authors:  Nicole J Kim; Cameron J Locke; Helen Park; Catherine Magee; Peter Bacchetti; Mandana Khalili
Journal:  J Gen Intern Med       Date:  2018-09-20       Impact factor: 5.128

2.  Emerging Opportunities to Improve Treatment Access for Substance Use Disorders and Other Comorbid Health Issues Among Women Enrolled in WIC.

Authors:  Yukiko Washio; Bradley N Collins; Linda M Kilby
Journal:  Health Promot Pract       Date:  2022-01-07

3.  Liver Disease Monitoring Practices After Hepatitis C Cure in the Underserved Population.

Authors:  Nicole J Kim; Catherine Magee; Cassie Cummings; Helen Park; Mandana Khalili
Journal:  Hepatol Commun       Date:  2018-09-24

4.  Hepatitis C Screening in an Underserved U.S. Cohort of Reproductive Age Women.

Authors:  Nicole J Kim; Daniel Holguin; Dylan Bush; Mandana Khalili
Journal:  Hepatol Commun       Date:  2019-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.